Decoy Therapeutics Inc. (DCOY) stock
DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.98−0.08 (-7.56%)
Close on Nov 13, 2026Market cap $638.94KP/E –Yield –
Decoy Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Decoy Therapeutics's enterprise value was -$7.71M on Nov 11, 2026, against $5.84M a year earlier. Over the last 5 years it ranged from -$7.72M to $236.75M, with a median of $19.08M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$7.71M | -403.0% |
| 2025 | Dec 31, 2025 | $2.54M | -91.1% |
| 2024 | Dec 31, 2024 | $28.54M | +23.3% |
| 2023 | Dec 29, 2023 | $23.14M | -5.5% |
| 2022 | Dec 30, 2022 | $24.48M | -89.7% |
| 2021 | Dec 31, 2021 | $236.75M | +14.5% |
| 2020 | Dec 31, 2020 | $206.85M | +24.3% |
| 2019 | Dec 31, 2019 | $166.37M | -90.7% |
| 2018 | Dec 31, 2018 | $1.78B | -90.3% |
| 2017 | Dec 29, 2017 | $18.33B | -29.8% |
| 2016 | Dec 30, 2016 | $26.10B | -54.7% |
| 2015 | Dec 31, 2015 | $57.61B | – |
See a number that looks wrong?